S. . Vranic, G. D. . Basu, D. W. . Hall, and Z. . Gatalica, “Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group”, ama, vol. 51, no. 3, pp. 217–231, Mar. 2023.